Trusted medical support in China for Mongolian patients
Cross-border care assistance · Standard service
China–Mongolia cross-border medical consultation is available. Contact us by phone or Facebook.Partner of the Third Central Hospital of Mongolia
Back to doctors
Yang Kun
Associate Chief Physician

Peking University Third Hospital · Endocrinology Department · Beijing

2017,, 、 、.:. 2 、 、 、. (2019 ) (2023 ) 12 [1] Tang R #, Wang J #, Zhang W, Fu W, Zhuo L, Yang J, Wang Q*, Kun Yang *. Eating window and eating habits of adults in China: A cross-sectional study. Heliyon. 2023. 9(6):e17233. [2] Liangbiao Gu #, Xiaona Cui, Xiafang Lin, Jin Yang, Rui Wei, Tianpei Hong*, Kun Yang *. γ -aminobutyric acid modulates α-cell hyperplasia but not β-cell regeneration induced by glucagon receptor antagonism in type 1 diabetic mice. Acta Diabetol. 2023. 60: 19-28. [3] L iu guoqiang #, Yang kun #, Le yunyi, Wei rui, Hong tianpei*, Yang jin*. High Vitamin D Level in Female Mice Increases the Number of Live Fetuses. J Nutr Sci Vitaminol (Tokyo). 2023. 69:1-6. [4] Yunyi Le #, Kun Yang #, Jin Yang, Wei Fu, Wenhua Xiao, Rui Wei*, Tianpei Hong*. Association of Time in Range with Endothelial Injury in Patients with Type 2 Diabetes Treated with Exenatide. Diabetes Ther. 2022. 13(10):1755-1767. [5] Yang K #, Wang H, Wei R, Xiao W, Tian Q, Wang C, Yang J *, Hong T*. High baseline FGF21 levels are associated with poor glucose-lowering efficacy of exenatide in patients with type 2 diabetes. Acta Diabetol. 2021. 58:595-602. [6] Wei R #, Cui X, Feng J, Gu L, Lang S, Wei T, Yang J, Liu J, Le Y, Wang H, Yang K *, Hong T*. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice. Metabolism. 2020. 111:154324. [7] Liu J #, Yang K #, Yang J, Xiao W, Le Y, Yu F, Gu L, Lang S, Tian Q, Jin T, Wei R*, Hong T*. Live-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output. EBioMedicine. 2019, 41:73-84. [8],, *... 2023. 31(11):852-857. [9],,, *. 1.. 2022. 30:348-352. [10],, *. 2018.. 2018. 26:265-269. [11],, *. -21:.. 2017. 56: 231-234. [12],, *,,. 2 -21.. 2017. 25: 394-397. 《 》、 《 》

Remove this favorite?